Health claim evaluation on grape seed extract and maintenance of normal blood pressure published by EFSA
Aug 31, 2021
On August 9, EFSA published an evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: MegaNaturalâBP grape seed extract and maintenance of normal blood pressure.
The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. MegaNatural娉BP, a grape seed extract standardised for total phenolics, gallic acid and the catechin and epicatechin content, is sufficiently characterised. The proposed claimed effect, maintenance of normal blood pressure (BP), is a beneficial physiological effect. Among the two human intervention studies provided from which conclusions could be drawn, one showed an effect of MegaNatural娉BP (300 mg/day) on BP in adults with normal and high normal BP when consumed daily for 6 weeks, whereas the second study did not show an effect of MegaNatural娉BP at the same daily dose consumed for 8 weeks in adults with normal and high normal blood pressure or stage 1 hypertension. The evidence provided did not establish a plausible mechanism by which the food could exert the claimed effect in vivo in humans. The evidence provided is insufficient to establish a cause and effect relationship between the consumption of MegaNatural娉BP and maintenance of normal blood pressure.
For further information (in English), click on the Link
Draft measure introduces DHA and ARA nutrient content and function claims
Malaysia
May 22, 2023
Regulation on Turkish Food Codex Nutrition Claims published
Turkey
Apr 27, 2023
Dietitians' and nutritionists' knowledge and views on aspects of health claims regulation in the UK: Do we inadvertently shoot the messenger?
UK
Apr 24, 2023
Food Labels: Trends in Use of Nutrition and Health Claims on New Zealand Foods and Beverages
New Zealand
Apr 10, 2023
ASA confirms that “suitable for diabetics” claim is misleading
UK
Apr 07, 2023
Health claim referring to the reduction of disease risk authorized
European Union
Mar 22, 2023
Around the World - Health and nutrition claims for infant formula: international cross sectional survey
USA
Feb 20, 2023
Qualified Health Claim for cocoa flavanols in high flavanol cocoa powder
USA
Feb 14, 2023
France allows the term ‘probiotic’ on food supplements labels
France
Jan 24, 2023
Optimizing the Relationship between Regulation and Innovation in Dietary Supplements: A Case Study of Food with Function Claims in Japan
Japan
Jan 19, 2023
China - Food and medicine continuum’ in the East and West: Old tradition and current regulation
China
Dec 22, 2022
Food Labeling Systems in Japan: Nutrition and Health Claims
Japan
Dec 08, 2022
Function and disease risk reduction claims
Thailand
Nov 24, 2022
FDA warns companies of using claims to treat cardiovascular disease
USA
Nov 17, 2022
A Critical Appraisal of the Separation Protocols Proposed for the Implementation of the Health Claim on “Olive Oil Polyphenols” (EC Regulation 432/2012)
European Union
Nov 14, 2022
Expertise in countries
- Argentina
- Australia
- Brazil
- Brunei
- Cambodia
- Canada
- Chile
- Colombia
- Ecuador
- Egypt
- European Union
- India
- Indonesia
- Laos
- Japan
- Malaysia
- Mexico
- Myanmar
- New Zealand
- Nigeria
- Paraguay
- Philippines
- Peru
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Switzerland
- Thailand
- Turkey
- UAE
- UK
- Ukraine
- Uruguay
- USA
- Vietnam
